1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNevada State Opioid Response Grant (SOR 4) is sponsored by Nevada Department of Health and Human Services, Bureau of Behavioral Health, Wellness and Prevention. Funding to support projects addressing the opioid and stimulant crisis in Nevada communities, running from January 1, 2025, through September 29, 2027.
Get alerted about grants like this
Save a search for “Nevada Department of Health and Human Services, Bureau of Behavioral Health, Wellness and Prevention” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Nonprofit organizations, local governments, and other community stakeholders in Nevada. Confirm the full requirements in the official notice before applying.
Nevada State Opioid Response Grant (SOR 4) is funded by Nevada Department of Health and Human Services, Bureau of Behavioral Health, Wellness and Prevention. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Nevada. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
SAMHSA's June 11 release of eight FY26 grant programs ranges from $600K to $9.2M and lands under the Trump-Kennedy-Burgum Great American Recovery Initiative. The SBIRT NOFO's 30-application cap means the deadline is functionally first-come, first-served.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleARPA-H's $139.4M EVIDENT initiative selects 13 research teams to build objective biomarkers for psilocybin, neuromodulation, and rapid-acting mental health therapies.
Read article